Skip to content

A study to investigate the mechanism of repetitive peripheral magnetic stimulation in the treatment of spasticity1

A study to investigate the mechanism of repetitive peripheral magnetic stimulation in the treatment of spasticity - Investigating the mechanism of treatment of spasticity in rPMS

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000051286
Enrollment
24
Registered
2023-06-08
Start date
2023-07-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

central motor palsy

Interventions

peripheral magnetic stimulation neuromuscular electrical stimulation

Sponsors

Keio University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Motor paralysis due to the unilateral lesion General condition is stable No evidence of cognitive decline or serious aphasia, and the patient is able to understand the study Written consent based on the patient's free will has been obtained after a thorough explanation of the study

Exclusion criteria

Exclusion criteria: 1) Those who have a cardiac pacemaker or artificial heart valve 2) Patients with an indwelling catheter in the heart 3) Patients with severe cardiac disease 4) Patients with obvious intracranial hypertension 5) Patients using a medical pump 6) Dependent on intra- or extracorporeal life support devices 7) Who have surgical clips or ferromagnetic materials in their body to stop bleeding 8) Who have a cochlear implant 9) Who may have metal fragments in their body 10) Persons with a history of convulsions or syncope 11) Persons with a history or family history of epilepsy 12) Persons with a history of suspected epilepsy or a family history of epilepsy 13) Persons with recent burns or skin lesions on the affected area 14) Patients with serious orthopedic complications that interfere with movement 15) Patients with a history of neuromuscular disease 16) Persons with other recent acute systemic illnesses or unstable general condition 17) Persons with severe dementia or complications of severe mental illness 18) Persons who may be pregnant 19) Other persons deemed inappropriate by the physician

Design outcomes

Primary

MeasureTime frame
Evaluate repressive inhibition before, immediately after, 15 minutes after, and 30 minutes after stimulation with rPMS or NMES.

Secondary

MeasureTime frame
- Spasticity (modified Ashworth scale, modified Tardieu scale, foot clonus) (pre-stimulation, 30 minutes after stimulation) - Physiological assessment (surface electromyography, motor evoked potentials) (pre-stimulation, immediately after stimulation, 15 minutes, 30 minutes after stimulation) - Joint range of motion (pre-stimulation, 30 minutes after stimulation)

Countries

Japan

Contacts

Public ContactTakayuki Kamimoto

Keio University School of Medicine Department of Rehabilitation Medicine

rw.mssl.720@gmail.com03-3353-1211

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026